Targeting treatment resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01
FKBPL and its peptide derivative, AD-01, have already demonstrated well-established inhibitory effects on breast cancer growth and CD44 dependent anti-angiogenic activity. FKBPL stable overexpression or AD-O! treatment were highly effective at reducing the BCSC population measured by inhibiting mamm...
| Main Author: | |
|---|---|
| Published: |
Queen's University Belfast
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.675459 |